Axsome Therapeutics, Inc. (AXSM)
232.06
-3.26
(-1.39%)
USD |
NASDAQ |
May 14, 16:00
232.06
0.00 (0.00%)
After-Hours: 18:47
Axsome Therapeutics Total Assets (Quarterly) : 713.61M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 128.68B |
| Indivior Pharmaceuticals, Inc. | 1.197B |
| Eli Lilly & Co. | 116.58B |
| Esperion Therapeutics, Inc. | 462.53M |
| Ocular Therapeutix, Inc. | 732.53M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 659.02M |
| Shareholders Equity (Quarterly) | 54.59M |
| Debt to Equity Ratio | 4.028 |
| Current Ratio | 1.392 |
| Net Debt Paydown Yield | -0.04% |